Bank of America
FOLD

Bank of America’s Amicus Therapeutics FOLD Stock Holding History

Bank of America’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.4M Buy
3,899,490
+461,249
+13% +$6.61M ﹤0.01% 1510
2025
Q4 		$49M Sell
3,438,241
-3,670,829
-52% -$36.1M ﹤0.01% 1578
2025
Q3 		$56M Buy
7,109,070
+261,795
+4% +$1.86M ﹤0.01% 1652
2025
Q2 		$39.2M Buy
6,847,275
+1,247,596
+22% +$8.05M ﹤0.01% 1912
2025
Q1 		$45.7M Buy
5,599,679
+1,562,350
+39% +$14.5M ﹤0.01% 1675
2024
Q4 		$38M Sell
4,037,329
-4,490
-0.1% -$46.7K ﹤0.01% 1732
2024
Q3 		$43.2M Buy
4,041,819
+1,460,806
+57% +$15.9M ﹤0.01% 1694
2024
Q2 		$25.6M Buy
2,581,013
+98,610
+4% +$1.01M ﹤0.01% 2008
2024
Q1 		$29.2M Sell
2,482,403
-226,132
-8% -$2.89M ﹤0.01% 1927
2023
Q4 		$38.4M Buy
2,708,535
+463,902
+21% +$5.27M ﹤0.01% 1559
2023
Q3 		$27.3M Sell
2,244,633
-134,269
-6% -$1.73M ﹤0.01% 1735
2023
Q2 		$29.9M Sell
2,378,902
-121,164
-5% -$1.44M ﹤0.01% 1675
2023
Q1 		$27.7M Buy
2,500,066
+147,769
+6% +$1.82M ﹤0.01% 1826
2022
Q4 		$28.7M Buy
2,352,297
+287,852
+14% +$3.24M ﹤0.01% 1716
2022
Q3 		$21.6M Buy
2,064,445
+107,592
+5% +$1.2M ﹤0.01% 1891
2022
Q2 		$21M Sell
1,956,853
-487,453
-20% -$4.01M ﹤0.01% 1980
2022
Q1 		$23.1M Buy
2,444,306
+438,886
+22% +$4.12M ﹤0.01% 2010
2021
Q4 		$23.2M Buy
2,005,420
+192,330
+11% +$2.14M ﹤0.01% 2075
2021
Q3 		$17.3M Buy
1,813,090
+51,484
+3% +$527K ﹤0.01% 2301
2021
Q2 		$17M Sell
1,761,606
-249,749
-12% -$2.44M ﹤0.01% 2284
2021
Q1 		$19.9M Buy
2,011,355
+1,011,055
+101% +$15.6M ﹤0.01% 2040
2020
Q4 		$23.1M Buy
1,000,300
+150,411
+18% +$3.08M ﹤0.01% 1747
2020
Q3 		$12M Buy
849,889
+151,793
+22% +$2.21M ﹤0.01% 2135
2020
Q2 		$10.5M Sell
698,096
-91,147
-12% -$1.11M ﹤0.01% 2166
2020
Q1 		$7.29M Buy
789,243
+180,550
+30% +$1.72M ﹤0.01% 2322
2019
Q4 		$5.93M Sell
608,693
-1,458,014
-71% -$13.3M ﹤0.01% 3076
2019
Q3 		$16.6M Buy
2,066,707
+280
+0% +$3.04K ﹤0.01% 2011
2019
Q2 		$25.8M Sell
2,066,427
-150,733
-7% -$1.91M ﹤0.01% 1638
2019
Q1 		$30.2M Buy
2,217,160
+563,954
+34% +$6.89M ﹤0.01% 1505
2018
Q4 		$15.8M Sell
1,653,206
-393,953
-19% -$4.33M ﹤0.01% 1874
2018
Q3 		$24.8M Buy
2,047,159
+1,366,695
+201% +$19.1M ﹤0.01% 1645
2018
Q2 		$10.6M Buy
680,464
+131,284
+24% +$1.98M ﹤0.01% 2397
2018
Q1 		$8.26M Sell
549,180
-102,837
-16% -$1.57M ﹤0.01% 2589
2017
Q4 		$9.38M Buy
652,017
+122,104
+23% +$1.68M ﹤0.01% 2512
2017
Q3 		$7.99M Buy
529,913
+467,770
+753% +$6.19M ﹤0.01% 2734
2017
Q2 		$626K Sell
62,143
-16,073
-21% -$129K ﹤0.01% 4761
2017
Q1 		$557K Sell
78,216
-64,487
-45% -$408K ﹤0.01% 4818
2016
Q4 		$709K Buy
142,703
+73,238
+105% +$507K ﹤0.01% 4580
2016
Q3 		$514K Buy
69,465
+6,715
+11% +$45.4K ﹤0.01% 4606
2016
Q2 		$343K Buy
62,750
+57,288
+1,049% +$401K ﹤0.01% 4906
2016
Q1 		$46K Sell
5,462
-66,930
-92% -$474K ﹤0.01% 5818
2015
Q4 		$703K Buy
72,392
+27,711
+62% +$250K ﹤0.01% 4605
2015
Q3 		$626K Sell
44,681
-8,393
-16% -$132K ﹤0.01% 4650
2015
Q2 		$751K Buy
53,074
+48,074
+961% +$578K ﹤0.01% 4357
2015
Q1 		$54K Sell
5,000
-13,489
-73% -$119K ﹤0.01% 5610
2014
Q4 		$154K Sell
18,489
-21,211
-53% -$146K ﹤0.01% 5574
2014
Q3 		$236K Sell
39,700
-59,784
-60% -$313K ﹤0.01% 5249
2014
Q2 		$333K Buy
99,484
+97,412
+4,701% +$229K ﹤0.01% 5024
2014
Q1 		$4K Sell
2,072
-15,427
-88% -$38.6K ﹤0.01% 7404
2013
Q4 		$41K Buy
17,499
+15,749
+900% +$34.6K ﹤0.01% 6675
2013
Q3 		$4K Sell
1,750
-2,054
-54% -$5.15K ﹤0.01% 7454
2013
Q2 		$9K Buy
+3,804
New +$11.7K ﹤0.01% 7187

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Bank of America's FOLD Position: Q1 2026 in Review

Bank of America increased its Amicus Therapeutics (FOLD) stake by 13% in Q1 2026, buying an estimated $6.61M and bringing the position to 3,899,490 shares worth $56.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1510.

Bank of America first reported a position in FOLD in Q2 2013 and has held it in 52 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Bank of America held 3,899,490 shares of Amicus Therapeutics worth $56.4M as of Q1 2026.
  • Bank of America bought 461,249 Amicus Therapeutics shares in Q1 2026, an estimated $6.61M.
  • Amicus Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1510 holding.
  • Bank of America first reported a position in Amicus Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.